FDA Approved: BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Actavis's fixed-dose combination analgesic Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate under NDA 0202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Tension-type Headache

Drugs mentioned

• Butalbital/Acetaminophen/Caffeine/Codeine Phosphate (Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate)

Snippet

SUPPL AP for BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE (BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE)